The Filing Desk

Camtek

CAMT · Nasdaq · Information Technology · Financials, fiscal 2016 to 2025

CAMT · Last close · November 19, 2026
$97.78

Camtek's revenue rose 15.6% to $496 million in fiscal 2025. Its operating margin was 25.8%, up from 25.2% a year earlier. Free cash flow was $127 million, up 13.7%. The diluted share count rose 1.2%.

Camtek Ltd. Latest fiscal year ended December 31, 2025 20-F filed March 19, 2026 · 0001178913-26-001561 Updated
Revenue
$496M
15.6%
Operating margin
25.8%
0.7 pts
Net income
$51M
57.2%
Free cash flow
$127M
13.7%
Return on capital
16.8%
0.5 pts

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.

About these figures. Camtek is a foreign company: it files an annual report on Form 20-F, prepared under US accounting standards (US GAAP), instead of a 10-K, and no quarterly reports, so this page has fiscal years only. Its shares trade in the US as American depositary shares (ADSs), and one ADS can stand for several ordinary shares, so per-share figures are per ordinary share and the page has no market value, P/E or valuation model. The SEC's structured data gives diluted share counts for fiscal 2016 to 2025 in thousands without saying so; they are shown here in millions, which makes net income per share match the reported earnings per share.

What Camtek does

Camtek, an Israeli company, makes inspection and metrology equipment for the semiconductor industry. Its machines scan silicon wafers during production, using optics and software to find defective chips and measure their features. Its customers are chipmakers, foundries and firms that assemble and test chips.

Its systems are used in advanced packaging, chiplets, high-bandwidth memory, compound semiconductors, memory chips, image sensors, power chips and similar fields. It sells systems and support worldwide, with direct customer support through subsidiaries in 8 offices. In November 2023 it bought FRT, a German supplier of precision measurement tools for advanced packaging and silicon carbide.

Its sales are concentrated in Asia. In 2025, sales in the Asia Pacific region, mostly China, Taiwan and South Korea, were about 91% of its total revenues.

Its biggest risks, as it describes them

  • Most of its sales come from Asia, so a downturn there or in China would hit it hard.
  • A few customers account for a large share of revenue.
  • Hostilities in Israel and nearby could disrupt its operations, shipments and supplies.
  • Two shareholders, Priortech and Chroma, vote together and share joint control over the company.
From Camtek's annual report on Form 20-F, filed March 19, 2026, in our words; the 20-F has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2025, earnings per share grew 26.0% a year and net income 30.2% a year, as new shares raised the share count by 41% and diluted each share's earnings.

Diluted earnings per share
US$ per ordinary share, fiscal years; loss years in red. One US-listed ADS can stand for several ordinary shares.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments242148139157257
Debt incl. finance leases195196197203525
Net debt (negative means net cash)−47485846269
Net debt to EBITDA−0.6x0.6x0.8x0.4x1.9x
Debt to equity0.7x0.5x0.4x0.4x0.8x
Interest coverage—————
Current ratio5.8x6.3x5.7x5.0x8.3x
Quick ratio5.1x5.5x4.8x4.1x7.3x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score4 of 97 of 96 of 9
Rule of 4020.9%62.2%41.3%
Altman Z''7.067.376.80
Accruals ratio−0.1%−0.4%−8.5%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets roseFailPassFail
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassPassFail
Current ratio roseFailFailPass
Share count didn't riseFailFailFail
Gross margin roseFailPassPass
Revenue rose relative to assetsFailPassPass
F-score4 of 97 of 96 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Camtek side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
CamtekFY2515.6%25.8%25.7%16.8%1.9x6
CohuFY2512.7%−15.4%2.4%−9.1%—5Compare
Veeco InstrumentsFY25−7.4%5.4%8.0%4.5%−3.0x6Compare
FormFactorFY252.8%7.3%1.5%6.8%−2.7x5Compare
Axcelis TechnologiesFY25−17.6%14.2%12.8%———Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue7994123134156270321315429496
Revenue growth14.2%18.0%31.8%8.8%16.3%73.0%19.0%−1.7%36.1%15.6%
Gross profit3246616573137160148210250
Research and development13141516202429323848
Operating income2−3202223718265108128
Net income51419222260807911851
Diluted EPS (US$)0.130.390.510.570.541.341.681.632.421.04
Diluted shares (millions)35363738404548494950
Cash flow
Cash from operations−172172526615879122142
Capital expenditure132124881014
Free cash flow−19−2152323575071112127
Dividends paid05570000600
Share buybacks0000000000
Acquisitions0000000000
Stock-based compensation01234610131417
Balance sheet at fiscal year end
Cash and short-term investments20445538106242148139157257
Debt incl. finance leases————0195196197203525
Total assets1061131421702885846777888921,260
Total liabilities3229403461290293312343643
Shareholders' equity7384101136227294384476549617
Margins and ratios
Gross margin41.0%48.7%49.4%48.3%47.0%50.9%49.8%46.8%48.9%50.5%
Operating margin2.5%−3.2%16.3%16.4%14.5%26.3%25.4%20.7%25.2%25.8%
Net margin6.0%14.9%15.2%16.4%14.0%22.4%24.9%24.9%27.6%10.2%
Free cash flow margin−23.5%−1.6%11.8%17.4%15.0%21.1%15.5%22.6%26.1%25.7%
Rule of 40 (growth + FCF margin)−9.3%16.4%43.6%26.2%31.3%94.1%34.5%20.9%62.2%41.3%
Return on capital—————32.3%21.8%12.2%17.3%16.8%
Return on equity6.7%17.7%20.2%18.5%12.0%23.1%23.6%18.3%23.1%8.7%
Return on assets4.3%12.8%14.7%14.1%9.5%13.8%12.7%10.7%14.1%4.7%
Net debt to EBITDA————−4.3x−0.6x0.6x0.8x0.4x1.9x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Camtek's Form 20-F filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Camtek.